05.07.2012 • News

BASF to Build Butadiene Extraction Plant in Antwerp

BASF plans to build a butadiene extraction plant at its Verbund site in Antwerp, Belgium. The plant will have an annual production capacity of 155,000 metric tons and is scheduled to start up during 2014.

The investment amount will be in the high double-digit million euro range.

The decision has been made in light of the increasingly tight supplies of butadiene on global markets. In recent years, the volumes of butadiene available on the market have declined sharply. At the same time, demand from the tire industry and other industries has been rising. This has led to a considerable increase in prices.

In Europe, BASF already operates a butadiene extraction plant at its Verbund site in Ludwigshafen, Germany, with an annual production capacity of 105,000 metric tons.

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.